期刊
INTERNATIONAL IMMUNOLOGY
卷 22, 期 1, 页码 1-6出版社
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxp104
关键词
adjuvant activity; CD1d; alpha-galactosylceramide; invariant V alpha 14J alpha 18; iNKT cell-targeted adjuvant therapy
类别
资金
- Japan Society for the Promotion of Science
Invariant NKT (iNKT) cells bridge innate and acquired immunity and play an important role in both protective and regulatory responses. The nature of the response is dictated by the initial cytokine environment: interaction with IL-10-producing cells induces negative regulatory T(h)2/regulatory T cell-type iNKT cells, while that with IL-12-producing cells results in pro-inflammatory T(h)1-type responses. Particularly, in the anti-tumor response, iNKT cells mediate adjuvant activity by their production of IFN-gamma, which in turn activates both innate and acquired immune systems. Thus, upon activation of iNKT cells, both MHC(-) and MHC(+) tumor cells can be efficiently eliminated. On the basis of these mechanisms, iNKT cell-targeted adjuvant cell therapies have been developed and have shown great promise in initial clinical trials on cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据